key: cord-0750440-k9ow8h9y
authors: Vanderlaan, Rachel
title: Commentary: Therapeutic Plasma Exchange in COVID -19 pediatric patients: Is there a role?
date: 2021-04-16
journal: JTCVS Tech
DOI: 10.1016/j.xjtc.2021.04.012
sha: fda5cdfbda3489c59fb9f0350b6b5882cc5d67b8
doc_id: 750440
cord_uid: k9ow8h9y

nan

Central message: This case highlights a multimodal approach of veno-veno extracorporeal membrane oxygenation and therapeutic plasma exchange in a teenage patient with respiratory failure attributed to COVID-19. Therapeutic plasma exchange (TPE) has shown some benefit in adult patients with severe sepsis and multi system organ failure 6 Recently published studies show reduction in C-reactive protein, interleukin-6, lactate dehydrogenase and D-Dimer in addition to improvement in oxygenation after TPE in critically ill COVID-19 adult patients 9, 10 . For patients with fulminant COVID-19 ARDS, TPE is emerging as a potential adjunct to the COVID -19 armamentarium; however, more research is needed to guide its potential use in adult patients.

There are no detailed reports of TPE in pediatric COVID-19 patients and how adult data applies to the pediatric population with severe COVID-19 infection is unclear. TPE has been described as a rescue therapy during the H1N1 pandemic in pediatric patients. Three children with acute lung injury and hemodynamic compromise underwent TPE after failure of conventional therapy and saw improvement in oxygenation and vasopressor support 11 . The report by Kakuturu and colleagues highlights the adjunct use of TPE and concomitant reduction in measured inflammatory markers, suggesting a temporal improvement related to TPE use.

This case report describes a 15 year old patient with many comorbidities found in adult COVID patients (obesity, pre-diabetes, hypertension) and how generalizable these results are to the broader pediatric population is not clear. However, Kakuturu and colleagues have provided important insights into care for this complex case with their successful use of VV-ECMO and TPE in a pediatric patient with severe ARDS attributed to COVID-19. Given the rare occurrence of severe SARS-CoV-2 in pediatric patient, multi-institutional discussions to delineate a role of TPE in critically ill pediatric COVID-19 patients is required.

J o u r n a l P r e -p r o o f

Extracorporeal Membrane Oxygenation in Children with Coronavirus Disease 2019: Preliminary Report from the Collaborative European Chapter of the Extracorporeal Life Support Organization Prospective Survey

Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study

Multisystem Inflammatory Syndrome in Children in New York State

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

Extracorporeal membrane oxygenation to treat a 15year old patient with severe COVID-19 respiratory failure

Plasmapheresis in severe sepsis and septic shock: A prospective, randomised, controlled trial

Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; A retrospective propensity matched control study

Plasma exchange in critically ill COVID-19 patients

Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19

Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A-An associated respiratory failure and hemodynamic shock